SavedAdd your journal

Journals / Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi / 2017 / Cilt: 8 - Sayı: 1

Antibiotic Sensitivity of the Escherichia Coli Strains Identified from Urine Samples

İdrar Örneklerinde Saptanan Escherichia Coli Suşlarının Antibiyotik Duyarlılığı

Mustafa GÜZEL
Doğan AKDOĞAN
Pages
38–42
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that, there was no İmipenem resistant strain, and the ESBL negative strains shown higher sensitivity rate than ESBL positive strains against the other antibiotics used in treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we aimed to evaluate the sensitivity of Fosfomycin and the other antibiotics against extended spectrum beta-lactamase (ESBL) negative and positive Escherichia Coli (E.
📊
Key Findings & Data:Material-Method: 100 ESBL positive and 100 ESBL negative E.
💡
Conclusion & Impact:It was found that, there was no İmipenem resistant strain, and the ESBL negative strains shown higher sensitivity rate than ESBL positive strains against the other antibiotics used in treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:İdrar · Escherichia Coli · Beta-Laktamaz

Abstract

Objective: In this study, we aimed to evaluate the sensitivity of Fosfomycin and the other antibiotics against extended spectrum beta-lactamase (ESBL) negative and positive Escherichia Coli (E. Coli) strains. Material-Method: 100 ESBL positive and 100 ESBL negative E. Coli strains isolated from urine cultures were included to the study. Antibiotic sensitivity was determined by Kirby-Bauer disk diffusion method and /or automated Phoenix with 100 systems. ESBL was investigated with combined disk diffusion method. Results: Fosfomycin sensitivity was found as 96% and 98% in ESBL positive and negative E. Coli strains, respectively. It was found that, there was no İmipenem resistant strain, and the ESBL negative strains shown higher sensitivity rate than ESBL positive strains against the other antibiotics used in treatment. Conclusions: As a result, it was thought that, the Fosfomycin, which is also easy to use in a single dose, can be used in the treatment of uncomplicated urinary system infections caused by both ESBL positive and ESBL negative E. coli strains. We consider that the reasons why no early complication are the patient selection, careful follow-up, and treatment of the patients in a newly established transplantation center.

Özet

Amaç: Bu çalışmada, Fosfomisin ve diğer antibiyotiklerin genişlemiş spektrumlu beta-laktamaz (GSBL) negatif ve pozitif Escherichia Coli (E. Coli) suşlarına karşı duyarlılık oranları incelenmesi amaçlanmıştır.

🔖

Cite This Article

GÜZEL, M., AKDOĞAN, D. (2017). Antibiotic Sensitivity of the Escherichia Coli Strains Identified from Urine Samples. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 8 - Sayı: 1, 38–42. https://ajindex.com/articles/363364

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. O’Connell SC. Management of patients with urinary disorders. In: Smeltzer SC, Bare BG, Hinkle JL, Cheever KH, editors. Brunner&Suddarth’s Textbook of Medicalsurgical Nursing. 12. ed. ABD: Lippincott Williams & Wilkins; 2009. p. 1359
  2. Tuncer İ, Karabayraktar A, Kart H, Baysal B. Üriner Sistem İnfeksiyonlarında Etken Mikroorganizmaların Görülme Sıklığı. SDÜ Tıp Fakültesi Dergisi. 1996; 3(3): 33-5
  3. Geerlings SE. Clinical Presentations and Epidemiology of Urinary Tract Infections. Microbiology spectrum. 2016; 4(5)
  4. Pietrucha-Dilanchian P, Hooton TM. Diagnosis, Treatment, and Prevention of Urinary Tract Infection. Microbiology spectrum. 2016; 4(6)
  5. Allocati N, Masulli M, Alexeyev MF, Di Ilio C. Escherichia coli in Europe: an overview. International journal of environmental research and public health. 2013; 10(12): 6235-54
  6. Köken G, Aşık G, Çiftçi İH, Çetinkaya Z, Aktepe OC, Yılmazer M. Toplum kökenli üriner sistem infeksiyonu etkeni Escherichia coli suşlarında fosfomisin trometamol etkinliği. ANKEM Dergisi. 2008; 22(1): 23-7
  7. Doğru A, Karatoka B, Ergen P, Aydın ÖŞ, Tigen ET. İdrar yolu enfeksiyonlarında direnç oranları: 2010 yılı verilerimiz. Turkish Journal of Urology. 2013; 39(4): 237-43
  8. Garau J. Other antimicrobials of interest in the era of extended-spectrum beta lactamases: fosfomycin, nitrofurantoin and tigecycline. Clin Mikrobiol Infect. 2008; 14(1): 198-202
  9. Baylan O. Fosfomisin: Dünü, bugünü ve geleceği. Mikrobiyol Bul. 2010; 44: 311-21
  10. Karadağ A, Tanrıverdi Çaycı Y, Bilgin K, Günaydın M, Eroğlu C. In vitro efcacy of fosfomycin against clinical strains. Journal of Microbiology and Infectious Diseases. 2014; 4(2): 55-8
  11. Institute CaLS. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement, CLSI document. Wayne, Pa, USA: Clinical and Laboratory Standards Institute; 2013
  12. Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. International journal of antimicrobial agents. 2009; 34(5): 407-13
  13. Aral M, Kireçci E, Doğan SŞ. İdrar örneklerinden izoleedilen gram negatif bakteriler ve antibiyotiklere direnç oranlarının retrospektif olarak değerlendirilmesi. Türk Mikrobiyol Cem Derg. 2011; 41(4): 139-42
  14. Bayram Y, Eren H, Berktaş M. İdrar örneklerinden izole edilen bakteriyel patojenlerin dağılımı ve GSBL pozitif ve nega